How it works
From first conversation to funded — 60 to 90 days.
Royalty financing is old, proven capital — pharmaceutical royalties have financed drug development for decades. Alya brings the same instrument to earlier-stage MedTech and BioTech, structured for Gulf institutional investors.
The process
Four steps, one thread.
Qualify
Weeks 1–2You share stage, clinical data, regulatory status and commercial plan. We assess fit against the region's health priorities and our investors' mandates — and give you a clear yes or no. No fees to find out.
Structure
Weeks 3–6With securities counsel, we set the royalty terms: the percentage of future product revenue, the term, and the caps. A dedicated special-purpose vehicle is formed for your raise, and the royalty right is issued as a regulated digital security under a Reg S framework on the ERC-3643 institutional standard — with investor identity verification and transfer restrictions enforced at the infrastructure level.
Raise
Weeks 6–10Your offering is introduced to a verified pool of Gulf family offices and institutional investors, through licensed intermediaries wherever the investor's jurisdiction requires it. Every participant clears KYC and AML checks before subscribing.
Distribute
Close and beyondCapital is deployed to your company at close. From first revenue, royalty distributions flow to investors on an agreed cadence, with transparent reporting on both sides.
The trade
What you keep — and what you give
You keep
- 100% of your equity — no dilution, ever
- Your board and full operating control
- Your intellectual property, unencumbered
- Upside beyond the royalty term
You give
A defined percentage of future product revenue, for a defined term. Nothing else.
If the product never generates revenue, there is nothing to repay.
Straight answers
The questions founders ask first.
Is this debt?
No. There is no principal, no interest and no repayment obligation. Investors are paid only from actual product revenue, only at the agreed percentage, only for the agreed term.
Is this crypto?
No. The digital security is a compliance wrapper — a regulated register of a conventional royalty contract. There is no public trading, no speculation mechanics, and every holder is identity-verified. The infrastructure standard, ERC-3643, exists precisely to enforce securities rules in software.
Who are the investors?
Gulf family offices and institutional investors with healthcare mandates, verified through KYC and AML before they can subscribe. You will know who holds your royalty.
What does it cost?
A structuring fee of 3–5% of the raise on close, plus administration — disclosed in full, in writing, before you commit to anything.
Sixty days from conversation to capital.
The qualification review is free and confidential.